CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

News Charles River Laboratories International, Inc. Börse Stuttgart

Equities

RV6

US1598641074

Market Closed - Börse Stuttgart Other stock markets 07:28:08 07/06/2024 pm IST			5-day change	1st Jan Change
199.4 ^EUR	-2.04%		+4.34%	-6.19%

07/06	The job report just threw a spanner in the works
07/06	Mizuho Initiates Charles River Laboratories International With Neutral Rating, $235 Price Target	MT

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

The job report just threw a spanner in the works	07/06
Charles River Laboratories Expands Access to CRADL Contract Vivarium Space in Somerville	07/06	AQ
Mizuho Initiates Charles River Laboratories International With Neutral Rating, $235 Price Target	07/06	MT
ANALYST RECOMMENDATIONS : Lyft, Amazon, Fedex, Xpo, Unilever...	07/06
Charles River Laboratories Opens New Contract Vivarium Space in Massachusetts	06/06	MT
The first rate cut	06/06
Charles River Laboratories Expands Access to CRADL® Contract Vivarium Space in Somerville	06/06	BU
Charles River Laboratories Expands Access to CRADL® Contract Vivarium Space in Somerville	06/06	CI
ANALYST RECOMMENDATIONS : American Airlines, Salesforce, Five Below, Tesla, Okta...	06/06
Transcript : Charles River Laboratories International, Inc. Presents at Jefferies 2024 Global Healthcare Conference, Jun-05-2024 10:00 AM	05/06
Transcript : Charles River Laboratories International, Inc. Presents at The 44th Annual William Blair Growth Stock Conference, Jun-04-2024 10:00 AM	04/06
Charles River Laboratories, Sanofi Collaborating to Develop Non-Animal Virtual Control Groups for Preclinical Trials	04/06	MT
Charles River Laboratories Announces Development of Nonclinical Virtual Control Groups with Sanofi to Reduce the Use of Animals in Research	04/06	BU
Charles River Laboratories to Present at William Blair and Jefferies Conferences	03/06	BU
Charles River Launches Viral Vector Tech Transfer Program to Safeguard Gene Therapy Development	30/05	BU
Charles River Laboratories International, Inc. Launches Viral Vector Tech Transfer Program to Safeguard Gene Therapy Development	30/05	CI
Transcript : Charles River Laboratories International, Inc. Presents at Bank of America Health Care Conference 2024, May-15-2024 10:00 AM	15/05
TD Cowen Adjusts Price Target on Charles River Laboratories International to $228 From $260	13/05	MT
Declaration of Voting Results of Charles River Laboratories International Inc	11/05	CI
JPMorgan Adjusts Price Target on Charles River Laboratories International to $270 From $280	10/05	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Charles River Laboratories International, Inc. Börse Stuttgart

Equities

RV6

US1598641074

Summary

Filters